Sidoti Csr Has Pessimistic View of Hawkins FY2027 Earnings

Hawkins, Inc. (NASDAQ:HWKNFree Report) – Research analysts at Sidoti Csr lowered their FY2027 earnings estimates for shares of Hawkins in a report released on Tuesday, February 3rd. Sidoti Csr analyst D. Harriman now forecasts that the specialty chemicals company will post earnings per share of $4.60 for the year, down from their prior estimate of $5.10. The consensus estimate for Hawkins’ current full-year earnings is $4.00 per share. Sidoti Csr also issued estimates for Hawkins’ Q3 2028 earnings at $1.01 EPS and FY2028 earnings at $5.10 EPS.

Other equities research analysts also recently issued reports about the company. Zacks Research upgraded Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. BWS Financial reaffirmed a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research report on Thursday, January 29th. Finally, Weiss Ratings cut shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 12th. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Hawkins presently has a consensus rating of “Hold” and an average price target of $162.50.

View Our Latest Stock Report on HWKN

Hawkins Trading Up 3.4%

Shares of HWKN opened at $134.38 on Thursday. Hawkins has a 12 month low of $98.30 and a 12 month high of $186.15. The stock’s 50-day moving average is $144.54 and its two-hundred day moving average is $155.17. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.35 and a quick ratio of 1.46. The stock has a market cap of $2.81 billion, a PE ratio of 34.02, a P/E/G ratio of 2.75 and a beta of 0.86.

Hawkins (NASDAQ:HWKNGet Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.03). Hawkins had a return on equity of 16.85% and a net margin of 7.75%.The business had revenue of $244.08 million for the quarter, compared to analysts’ expectations of $252.51 million.

Institutional Investors Weigh In On Hawkins

Institutional investors have recently made changes to their positions in the company. Montanaro Asset Management Ltd lifted its position in Hawkins by 294.0% in the 2nd quarter. Montanaro Asset Management Ltd now owns 59,100 shares of the specialty chemicals company’s stock valued at $8,398,000 after purchasing an additional 44,100 shares during the last quarter. Callan Family Office LLC acquired a new stake in shares of Hawkins in the third quarter valued at approximately $1,568,000. Neuberger Berman Group LLC bought a new stake in shares of Hawkins during the second quarter valued at approximately $4,594,000. Sequoia Financial Advisors LLC acquired a new position in shares of Hawkins during the second quarter worth approximately $332,000. Finally, Geode Capital Management LLC grew its holdings in Hawkins by 1.1% in the 2nd quarter. Geode Capital Management LLC now owns 478,348 shares of the specialty chemicals company’s stock worth $67,981,000 after buying an additional 5,110 shares in the last quarter. 69.71% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director James A. Faulconbridge acquired 1,500 shares of the business’s stock in a transaction on Wednesday, February 4th. The shares were purchased at an average price of $129.29 per share, for a total transaction of $193,935.00. Following the completion of the purchase, the director directly owned 50,907 shares of the company’s stock, valued at $6,581,766.03. This represents a 3.04% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 4.10% of the stock is currently owned by corporate insiders.

Hawkins Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, February 13th. Hawkins’s dividend payout ratio (DPR) is 19.24%.

Trending Headlines about Hawkins

Here are the key news stories impacting Hawkins this week:

  • Positive Sentiment: Director James A. Faulconbridge increased his stake, purchasing 1,500 shares at an average $129.29 (total ~$193,935), bringing his holdings to ~50,907 shares (worth ~ $6.58M). Insider buying by a director is typically viewed as a confidence signal and likely helped lift the stock. Top Insider Just Made a Big Bet on This Under-the-Radar Company SEC Form 4
  • Neutral Sentiment: Reported short interest shows 0 shares and a 0.0 days-to-cover ratio — this appears to be a reporting artifact or a very low short interest reading. Low/zero short interest reduces short-squeeze risk but offers limited directional insight. (Source: market data entry)
  • Negative Sentiment: Sidoti (coverage) trimmed its FY2027 EPS estimate for Hawkins from $5.10 to $4.60 and published a cautious near-term view; the firm projects FY2028 at $5.10 and Q3 2028 at $1.01. Analyst downgrades can pressure the stock by lowering near-term expectations and investor sentiment. Sidoti Csr Has Pessimistic View of Hawkins FY2026 Earnings

About Hawkins

(Get Free Report)

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.

Featured Stories

Earnings History and Estimates for Hawkins (NASDAQ:HWKN)

Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.